0000899243-21-040821.txt : 20211020
0000899243-21-040821.hdr.sgml : 20211020
20211020183615
ACCESSION NUMBER: 0000899243-21-040821
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210610
FILED AS OF DATE: 20211020
DATE AS OF CHANGE: 20211020
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lee Christopher G
CENTRAL INDEX KEY: 0001887223
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40053
FILM NUMBER: 211335165
MAIL ADDRESS:
STREET 1: 7353 COMPANY DRIVE
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46237
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Apria, Inc.
CENTRAL INDEX KEY: 0001735803
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082]
IRS NUMBER: 824937641
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7353 COMPANY DRIVE
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46237
BUSINESS PHONE: 800-990-9799
MAIL ADDRESS:
STREET 1: 7353 COMPANY DRIVE
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46237
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-10
0
0001735803
Apria, Inc.
APR
0001887223
Lee Christopher G
C/O APRIA, INC.
7353 COMPANY DRIVE
INDIANAPOLIS
IN
46237
0
1
0
0
Chief Accounting Officer
Common Stock
2021-08-10
4
M
0
2700
4.67
A
2700
D
Common Stock
2021-08-10
4
F
0
1205
30.51
D
1495
D
Common Stock
2021-08-11
4
S
0
1059
30.55
D
436
D
Common Stock
2021-08-11
4
S
0
436
31.60
D
0
D
Common Stock
2021-09-20
4
M
0
2700
4.67
A
2700
D
Common Stock
2021-09-20
4
F
0
1155
37.29
D
1545
D
Common Stock
2021-09-23
4
S
0
1179
36.57
D
366
D
Common Stock
2021-09-23
4
S
0
366
37.22
D
0
D
Common Stock
2021-10-18
4
M
0
2700
4.67
A
2700
D
Common Stock
2021-10-18
4
F
0
1176
34.17
D
1524
D
Restricted Stock Units
2021-06-10
4
A
0
1854
0.00
A
Common Stock
1854
1854
D
Stock Appreciation Right
4.67
2021-08-10
4
M
0
2700
0.00
D
2027-03-09
Common Stock
2700
5746
D
Stock Appreciation Right
4.67
2021-09-20
4
M
0
2700
0.00
D
2027-03-09
Common Stock
2700
3046
D
Stock Appreciation Right
4.67
2021-10-18
4
M
0
2700
0.00
D
2027-03-09
Common Stock
2700
346
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 28, 2021.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $30.03 to $31.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $31.14 to $32.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $36.09 to $37.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $37.09 to $37.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer ("Common Stock"). The restricted stock units will be settled in either Common Stock or cash (or a combination thereof) at the discretion of the Issuer's compensation committee.
These restricted stock units vest in three equal annual installments beginning on June 10, 2022, subject to the Reporting Person's continued employment on the applicable vesting date.
These stock appreciation rights are fully vested.
/s/ Timothy Maloche, as Attorney-in-Fact
2021-10-20